Reasons may include: Dose too low Irregular injection schedule Diet and lifestyle inconsistencies Underlying hormonal or metabolic issues If progress is slower than expected, a provider may review: Relevant labs and health markers Medication tolerance and dosing Nutrition, movement, sleep, and stress patterns Whether the care plan should continue, change, or stop This is why provider-guided monitoring can help personalize care and support safer treatment decisions
Not a guide for human or animal use
Your role is to bring clarity, help clients avoid compliance missteps, and position coverage decisions as thoughtful, evidence-based, and fair
However, hypoglycemia risk increases significantly when combined with insulin or sulfonylureas, often requiring dose adjustments of these concomitant medications
[2] Greenwood-Van Meerveld B, Tyler K, Mohammadi E, Pietra C
Retatrutide at 12mg produces an average of 28.7% total body weight reduction over 48 weeks in clinical trials